Terns Pharmaceuticals, Inc. (TERN) DCF Valuation

Terns Pharmaceuticals, Inc. (TERN) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Terns Pharmaceuticals, Inc. (TERN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (TERN) DCF Calculator! Utilizing up-to-date data from Terns Pharmaceuticals, Inc. and customizable assumptions, this tool empowers you to forecast, evaluate, and assess the value of (TERN) like an expert investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 1.0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -100 0 -25 -25 -25 -25 -25
EBITDA -35.0 -36.6 -49.3 -59.0 -102.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 -4934.8 100 100 60 60 60 60 60
Depreciation .2 .4 .5 1.0 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 51.2 100 100 90.24 90.24 90.24 90.24 90.24
EBIT -35.2 -37.0 -49.9 -60.0 -102.9 .0 .0 .0 .0 .0
EBIT, % 100 100 -4986 100 100 60 60 60 60 60
Total Cash 19.7 74.9 166.0 283.1 263.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 12.7 .0 .0 .0
Account Receivables, % 100 100 0 100 100
Inventories .0 3.0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 0 100 100 80 80 80 80 80
Accounts Payable 1.6 .9 2.1 1.6 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 212.6 100 100 100 100 100 100 100
Capital Expenditure -.9 -.6 -.3 -.3 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -34 100 100 -6.8 -6.8 -6.8 -6.8 -6.8
Tax Rate, % -0.26564 -0.26564 -0.26564 -0.26564 -0.26564 -0.26564 -0.26564 -0.26564 -0.26564 -0.26564
EBITAT -35.2 -37.8 -50.4 -60.3 -103.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -34.3 -54.4 -33.3 -60.1 -102.0 -2.5 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -79
Equity Value 77
Diluted Shares Outstanding, MM 71
Equity Value Per Share 1.08

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real TERN financials.
  • Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect Terns Pharmaceuticals’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Terns Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify editable cells highlighted in yellow, such as WACC, growth rates, and profit margins.
  • Automated Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
  • Designed for All Skill Levels: An easy-to-navigate layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Download: Access the ready-to-use Excel file with Terns Pharmaceuticals, Inc. (TERN) financial data.
  • Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations update in real-time.
  • Test Scenarios: Create multiple projections and compare outcomes instantly.
  • Make Decisions: Use the valuation results to guide your investment strategy.

Why Choose Terns Pharmaceuticals, Inc. (TERN)?

  • Innovative Solutions: Cutting-edge therapies developed to address unmet medical needs.
  • Proven Expertise: A team of seasoned professionals with extensive industry experience.
  • Commitment to Quality: Rigorous standards ensure the highest level of product integrity.
  • Patient-Centric Approach: Focused on improving patient outcomes and quality of life.
  • Strong Partnerships: Collaborations with leading organizations to enhance research and development.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Terns Pharmaceuticals stock (TERN).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Terns Pharmaceuticals (TERN).
  • Consultants: Deliver professional valuation insights to clients quickly and accurately, focusing on Terns Pharmaceuticals (TERN).
  • Business Owners: Understand how biopharmaceutical companies like Terns Pharmaceuticals are valued to guide your own strategy (TERN).
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Terns Pharmaceuticals (TERN).

What the Template Contains

  • Historical Data: Includes Terns Pharmaceuticals’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Terns Pharmaceuticals’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Terns Pharmaceuticals’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.